bf/NASDAQ:CLOV_icon.jpeg

COM:CLOVERHEALTH

Clover Health

  • Stock

Last Close

3.36

22/11 21:00

Market Cap

665.23M

Beta: -

Volume Today

3.90M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-363.74M
-
-6.74M
98.15%
-587.76M
8,614.16%
-338.84M
42.35%
-213.36M
37.03%
depreciation and amortization
551K
-
555K
0.73%
1.25M
124.50%
1.19M
4.74%
2.51M
111.37%
deferred income tax
143.01M
-
-7.63M
105.34%
-66.09M
765.88%
-4.74M
-
stock based compensation
3.30M
-
7.08M
114.42%
163.72M
2,213.13%
164.31M
0.36%
140.93M
14.23%
change in working capital
32.31M
-
4.63M
85.65%
192.67M
4,056.94%
98.31M
48.97%
-55.43M
156.38%
accounts receivables
-6.96M
-
-34.53M
395.76%
-9.39M
72.80%
-8.03M
14.50%
inventory
6.96M
-
2.23M
67.98%
9.39M
321.13%
8.03M
14.50%
accounts payables
6.30M
-
10.85M
72.20%
5.31M
51.07%
7.63M
43.87%
4.74M
37.93%
other working capital
26.01M
-
26.09M
0.31%
187.37M
618.15%
90.68M
51.60%
-60.17M
166.36%
other non cash items
24.69M
-
-117.25K
100.47%
13.88M
11,938.30%
-128.89M
1,028.53%
14.22M
111.04%
net cash provided by operating activities
-159.88M
-
-2.23M
98.61%
-282.33M
12,576.74%
-203.93M
27.77%
-115.87M
43.18%
investments in property plant and equipment
-23K
-
-693K
2,913.04%
-723K
4.33%
-4.47M
517.84%
-584K
86.93%
acquisitions net
-1.18M
-
3.90M
430.76%
434.72M
11,038.20%
-16.20M
103.73%
purchases of investments
-505.55M
-
-174.32M
65.52%
-876.25M
402.67%
-369.65M
57.82%
-175.57M
52.50%
sales maturities of investments
324.84M
-
312.42M
3.82%
441.53M
41.33%
485.45M
9.95%
316.16M
34.87%
other investing activites
-969.31M
-
-434.72M
55.15%
net cash used for investing activites
-181.91M
-
-828M
355.18%
-435.45M
47.41%
95.13M
121.85%
140.01M
47.18%
debt repayment
-9.67M
-
-300K
96.90%
-30.93M
10,208.33%
common stock issued
601K
-
813.63M
135,278.54%
289.92M
64.37%
1.40M
99.52%
1.15M
17.86%
common stock repurchased
-957K
-
-147K
84.64%
-6.36M
4,227.89%
-6.22M
2.23%
dividends paid
-957K
-
-305K
68.13%
other financing activites
343.05M
-
46.82M
86.35%
666.85M
1,324.31%
-28.79M
-
net cash used provided by financing activities
333.98M
-
858.23M
156.97%
925.39M
7.83%
-4.96M
100.54%
-33.86M
582.41%
effect of forex changes on cash
-67.60M
-
-106.15M
-
net change in cash
-7.80M
-
-39.59M
407.30%
207.62M
624.36%
-113.75M
154.79%
-9.72M
91.46%
cash at beginning of period
75.40M
-
67.60M
10.35%
92.35M
36.61%
299.97M
224.82%
186.21M
37.92%
cash at end of period
67.60M
-
28.00M
58.57%
299.97M
971.19%
186.21M
37.92%
176.49M
5.22%
operating cash flow
-159.88M
-
-2.23M
98.61%
-282.33M
12,576.74%
-203.93M
27.77%
-115.87M
43.18%
capital expenditure
-23K
-
-693K
2,913.04%
-723K
4.33%
-4.47M
517.84%
-584K
86.93%
free cash flow
-159.90M
-
-2.92M
98.17%
-283.05M
9,593.07%
-208.39M
26.38%
-116.45M
44.12%

All numbers in (except ratios and percentages)